Microbiological Testing/Measurement TRIZ Cases

Structural electronegativity encoding maps ionic current signals to biopolymer monomers using a neural network.

Electrochemical pH modulation differentiates overlapping fluorescent probes in real-time qPCR, eliminating sample loss from buffer exchange.

Cyclized plasma DNA enables high-throughput sequencing of fetal deafness mutations, resolving invasive diagnostic risks.

FISH probes resolve low-resolution CGH limitations by targeting specific ESR1 loci, enabling precise patient selection for tailored anti-estrogen therapy.

Identifying BRCA1 mutations replaces time-consuming in vitro testing with direct molecular marker detection for accurate chemosensitivity prediction.

Flow cytometry quantifies antimicrobial levels using microbial strain incubation and fluorophore detection.

A glucose sensor reagent uses a phenothiazine mediator to enhance fill rate, reducing background current for stable readings.

A scoring method processes genotypic information from multiple biallelic polymorphic loci to assess individual medical risk.

A microbial quantitation system adds synthetic spike-in nucleic acids to soil samples for sequencing analysis.

Enzymatic cleavage removes PEG linkers to isolate deamidation-induced acidic species, resolving measurement inaccuracies caused by linker hydrolysis.

A methylome-based predictor analyzes DNA methylation profiles to forecast meningioma recurrence risk.

Benzonase Nuclease degrades eukaryotic DNA during selective lysis, resolving filterability bottlenecks in high-density bioreactor samples.

A culture medium uses chromogenic substrates to detect Vibrio bacteria.

Specific PCR primers and probes replace complex microscopy to quantify foaming bacteria, reducing analysis time and equipment costs.

Nucleotide imbalance fidelity assays amplify error rates during DNA synthesis to enable high-resolution polymerase characterization.

A single-step cell lysis method combines heat, detergent, and base to extract high molecular weight genomic DNA.

Measuring glutaminyl cyclase levels in biological fluids enables neurodegenerative disease detection.

Digital PCR partitions nucleic acid samples to co-detect multiple target genes within single genomes, eliminating culture isolation delays.

Targeted cerebrospinal fluid biomarker assays resolve diagnostic delays by identifying specific protein signatures for early multiple sclerosis intervention.

Intramolecular elongation distributes molecular barcodes along nucleic acid strands for high-throughput sequencing applications.

Light cleaves photocleavable groups to assemble spatial barcodes on nucleic acids for precise molecular localization.

Nucleic acid probes hybridize to Plasmodium knowlesi sequences, resolving detection precision versus equipment complexity constraints.

LNA modified primers enable sensitive nucleic acid detection via isothermal amplification, eliminating complex RNA extraction steps and reducing testing costs.

Universal primers enable simultaneous amplification of multiple cDNA targets, reducing hands-on time and reagent consumption for clinical miRNA analysis.

Polymerized enzyme conjugates bind multiple signal-generating molecules to analytes, resolving insufficient detection sensitivity in biological assays.

PDE8A pre-mRNA editing profile serves as a specific biomarker for quantifying ADARs enzymatic activity in human peripheral tissues.

A biosensor cartridge system concentrates microorganisms onto a detection surface through electrophoresis.

Automated magnetic separation isolates nucleic acids using functionalized particles and lithium salt lysis buffers, eliminating hazardous phenol reagents.

Amino-spacer-COOH moieties increase molecular probe density on digital barcoded magnetic beads.

Adding a complexing agent converts sparingly soluble salts into dissolved form, preventing nucleic acid binding and enhancing detection sensitivity.

A method for modulating protein levels in eukaryotic organisms by generating single nucleotide polymorphisms within the translation initiation sequence.

Detecting the IGVL3-21*01 allele identifies individuals at risk for chronic lymphocytic leukemia.

Detecting CGB1 and CGB2 gene expression levels identifies aggressive epithelial cancer phenotypes using RT-PCR and nucleic acid sequencing.

Segmented chimeric G alpha subunits enhance potassium ion transport sensitivity for precise chemical substance detection.

Direct adaptor ligation using 5'-phosphorylated primers eliminates T4 PNK optimization complexity and base bias in library construction.

Separates nanoparticles by DNA valency via complementary binding, resolving mixtures caused by random attachment.

Encoded microcarriers merge multiple singleplex assays into one reaction vessel, reducing sample volume and assay time while maintaining detection accuracy.

Circularizing phosphorylated RNA fragments enables direct Oxford Nanopore sequencing without PCR amplification.

Segmented local and global noise models correct probe ratios in microarray data, resolving precision trade-offs to detect amplified or deleted DNA subsequences.

Multi-layered biomarker analysis identifies patient risk through integrated miRNA and protein expression data.

Quantifies HEC1, CEACAM6, HYAL1, and MMP-1 expression to calculate a cancer risk score for precancerous breast tumors.

Differential cell lysis releases intracellular adenylate kinase from microorganisms while leaving host cells intact.

Segmenting amplification into isolated dendritic units ensures monoclonal clusters, resolving substrate patterning complexity.

Immunofluorescence assays quantify PD-L1 expression on circulating tumor cells in blood samples to identify candidates for targeted immunotherapy.

Significance index metrics quantify associations between microorganism taxa and health conditions using reference features.

KASP primers detect SNP mutations in soybeans, replacing slow phenotypic screening with precise genetic analysis.